{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:50:01Z","timestamp":1791474601545,"version":"4.3.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Bladder urothelial carcinoma (BUC) remains a highly recurrent and heterogeneous malignancy. Accurate postoperative risk stratification is crucial to guide adjuvant therapy decisions. We hypothesized that integrating Uroplakin III (UPK3A protein)protein expression with systemic inflammation markers and demographic factors could improve prognostic prediction through advanced machine learning(ML) models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study analyzed 1,032 BUC patients who underwent radical cystectomy. Clinical, pathological, and serological data, including immunohistochemical UPK3A protein expression, were collected. Least Absolute Shrinkage and Selection Operator (LASSO) regression with \u03bb=0.009 (determined via 10-fold cross-validation) was used for feature selection. Nine ML models were trained and validated. Model performance was assessed using Area Under the Receiver Operating Characteristic Curve (AUC-ROC), calibration curves, decision curve analysis (DCA), and clinical impact curves (CIC). Model interpretability was evaluated with SHapley Additive exPlanations (SHAP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Light Gradient Boosting Machine(LightGBM), Random Forest(RF), and Extreme Gradient Boosting (XGBoost) models demonstrated superior performance (AUCs: 0.894\/0.754 for RF in training\/test sets). SHAP analysis highlighted vascular invasion, tumor necrosis, and UPK3A protein as key predictors. CIC demonstrated strong clinical utility. Integrating UPK3A protein with inflammatory and demographic variables outperformed traditional models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The combination of UPK3A protein expression with multimodal features significantly enhances prognostic modeling in BUC. This approach offers a promising clinical decision support tool to stratify risk and guide postoperative management. Future studies should incorporate transcriptomic\/proteomic data to further validate these findings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1636358","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:13:07Z","timestamp":1758255187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Multimodal prognostic models for bladder urothelial carcinoma: uroplakin III combined with serum and demographic data"],"prefix":"10.3389","volume":"15","author":[{"given":"Runlin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.03.001","article-title":"ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00262-021-02953-0","article-title":"Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer","volume":"71","author":"Schuettfort","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.07.002","article-title":"Nomogram predicting bladder cancer-specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium","volume":"7","author":"Mir","year":"2021","journal-title":"Eur Urol Focus"},{"key":"B4","article-title":"Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder","volume":"9","author":"Koga","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/path.1252","article-title":"Uroplakin gene expression in normal human tissues and locally advanced bladder cancer","volume":"199","author":"Olsburgh","year":"2003","journal-title":"J Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20902","article-title":"Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs","volume":"103","author":"Eissa","year":"2005","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4(+) T cells mediate anti-tumor cytotoxicity in human bladder cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eururo.2024.01.023","article-title":"Prognostic impact and spatial interplay of immune cells in urothelial cancer","volume":"86","author":"Debatin","year":"2024","journal-title":"Eur Urol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama"},{"key":"B10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.032","article-title":"Augmented bladder tumor detection using deep learning","volume":"76","author":"Shkolyar","year":"2019","journal-title":"Eur Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000001516","article-title":"Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8 + T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1004913","article-title":"A comparative analysis of eight machine learning models for the prediction of lateral lymph node metastasis in patients with papillary thyroid carcinoma","volume":"13","author":"Feng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1951527","article-title":"Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features","volume":"12","author":"Lei","year":"2021","journal-title":"Bioengineered"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8503511","article-title":"Analysis of lymphoma-related genes with gene ontology and kyoto encyclopedia of genes and genomes enrichment","volume":"2022","author":"Sun","year":"2022","journal-title":"BioMed Res Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.11.128","article-title":"Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer","volume":"72","author":"Matsumoto","year":"2008","journal-title":"Urology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.11.045","article-title":"UPK3A: a promising novel urinary marker for the detection of bladder cancer","volume":"76","author":"Lai","year":"2010","journal-title":"Urology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.4.1539","article-title":"High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancer","volume":"16","author":"Tsumura","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-014-1329-y","article-title":"Urothelial carcinogen resistance driven by stronger Toll-like receptor 2 (TLR2) and Uroplakin III (UP III) defense mechanisms: a new model","volume":"33","author":"Reis","year":"2015","journal-title":"World J Urol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100785","article-title":"Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study","volume":"3","author":"Hu","year":"2022","journal-title":"Cell Rep Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70033","article-title":"Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48-ADC) combined immunotherapy in patients with muscle-invasive bladder cancer: A multi-center real-world study","volume":"4","author":"Hu","year":"2025","journal-title":"Imeta"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13480","article-title":"High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced\/metastatic urothelial bladder cancer","volume":"25","author":"Tan","year":"2018","journal-title":"Int J Urol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/iju.12766","article-title":"Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study","volume":"22","author":"Taguchi","year":"2015","journal-title":"Int J Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30030197","article-title":"Predictive value of inflammatory and nutritional indexes in the pathology of bladder cancer patients treated with radical cystectomy","volume":"30","author":"Prijovic","year":"2023","journal-title":"Curr Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4111\/icu.20230435","article-title":"Applications of artificial intelligence in urologic oncology","volume":"65","author":"Pak","year":"2024","journal-title":"Investig Clin Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.03.012","article-title":"Artificial intelligence in urological oncology: An update and future applications","volume":"39","author":"Brodie","year":"2021","journal-title":"Urol Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.09.035","article-title":"EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multistakeholder effort(\u2020): under the auspices of the EAU-ESMO guidelines committees","volume":"77","author":"Witjes","year":"2020","journal-title":"Eur Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4281","article-title":"Bladder cancer, ESMO 2016","volume":"10","author":"So","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu223","article-title":"Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up","author":"Bellmunt","year":"2014","journal-title":"Ann Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1338","article-title":"Integrated single-cell and spatial transcriptomic profiling reveals higher intratumor heterogeneity and epithelial-fibroblast interactions in recurrent bladder cancer","volume":"13","author":"Shi","year":"2023","journal-title":"Clin Transl Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10142-025-01642-w","article-title":"Comprehensive multi-omics analysis of nucleotide metabolism: elucidating the role and prognostic significance of UCK2 in bladder cancer","volume":"25","author":"Guo","year":"2025","journal-title":"Funct Integr Genomics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1301157","article-title":"Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1636358\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:13:10Z","timestamp":1758255190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1636358\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":32,"alternative-id":["10.3389\/fonc.2025.1636358"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1636358","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"article-number":"1636358"}}